Compile Data Set for Download or QSAR
Report error Found 32 Enz. Inhib. hit(s) with all data for entry = 7715
TargetFatty acid-binding protein, adipocyte(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212456(US9278918, 46)
Affinity DataIC50: 50nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein, adipocyte(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212452(US9278918, 42)
Affinity DataIC50: 60nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein, adipocyte(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212455(US9278918, 45)
Affinity DataIC50: 80nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein, adipocyte(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212454(US9278918, 44)
Affinity DataIC50: 100nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein, adipocyte(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212448(US9278918, 34)
Affinity DataIC50: 140nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein, adipocyte(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212451(US9278918, 41)
Affinity DataIC50: 140nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein, adipocyte(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212447(US9278918, 33)
Affinity DataIC50: 150nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein, adipocyte(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212460(US9278918, 50)
Affinity DataIC50: 290nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein, adipocyte(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212450(US9278918, 40)
Affinity DataIC50: 330nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein, adipocyte(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212457(US9278918, 47)
Affinity DataIC50: 520nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein, adipocyte(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212459(US9278918, 49)
Affinity DataIC50: 750nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein, adipocyte(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212449(US9278918, 35)
Affinity DataIC50: 810nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein, adipocyte(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212453(US9278918, 43)
Affinity DataIC50: 890nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein, adipocyte(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212458(US9278918, 48)
Affinity DataIC50: 950nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein, adipocyte(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212461(US9278918, 51)
Affinity DataIC50: 1.35E+3nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212456(US9278918, 46)
Affinity DataIC50: 3.79E+3nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein, adipocyte(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212446(US9278918, 32)
Affinity DataIC50: 4.26E+3nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212457(US9278918, 47)
Affinity DataIC50: 6.35E+3nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212454(US9278918, 44)
Affinity DataIC50: 1.37E+4nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212461(US9278918, 51)
Affinity DataIC50: 1.71E+4nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212451(US9278918, 41)
Affinity DataIC50: 1.96E+4nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212447(US9278918, 33)
Affinity DataIC50: 2.36E+4nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212455(US9278918, 45)
Affinity DataIC50: 2.83E+4nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212453(US9278918, 43)
Affinity DataIC50: 5.00E+4nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212452(US9278918, 42)
Affinity DataIC50: 5.00E+4nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212449(US9278918, 35)
Affinity DataIC50: 5.00E+4nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212448(US9278918, 34)
Affinity DataIC50: 5.00E+4nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212450(US9278918, 40)
Affinity DataIC50: 5.00E+4nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212460(US9278918, 50)
Affinity DataIC50: 5.00E+4nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212446(US9278918, 32)
Affinity DataIC50: 5.00E+4nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212459(US9278918, 49)
Affinity DataIC50: 5.00E+4nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent

TargetFatty acid-binding protein 5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM212458(US9278918, 48)
Affinity DataIC50: 5.00E+4nMpH: 7.5 T: 2°CAssay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 uM to 0.003 uM final compound conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2017
Entry Details
US Patent